Efficacy of PERT for PEI in Unresectable Pancreatic Cancer.

NCT06099119 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

100

Enrollment

OTHER

Sponsor class

Conditions

Unresectable Pancreatic Cancer

Interventions

DRUG: creon 35.000 Ph.U (R)
OTHER: Best Standarard of Care

Sponsor

Hospital Clinico Universitario de Santiago

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]